Canadian Pharmaceutical Sales ManagementCutting Edge InformationNovember 1, 2007 151 Pages - SKU: CIGQ1627679 |
| Countries covered: Canada In Canada, access to physicians remains one of the top problems of the day for pharmaceutical sales organizations. Though not nearly as overrun as US doctors, top prescribing Canadian physicians can still expect to see as many as 4 to 6 different reps from some larger companies during a given month. Combining access issues with stringent self-imposed and government regulations on how reps can sell their products and companies are scrambling to develop new and innovative sales strategies and tactics to stand out in a crowded market. As the industry continues to evolve in the age of reduced access, patent expiry, generic incursion and slow pipelines, executives who focus resources on key strategic points now while effectively managing their sales forces will outpace their competition. Cutting Edge Information’s report Canadian Pharmaceutical Sales Management analyzes present trends to provide the steps pharmaceutical sales managers must take to stay competitive - and beat the market. The report makes its case with metrics and techniques for managing all three aspects of the current sales landscape:
|
Additional Information
Companies Included in Report
EMD Serono
Genzyme
GlaxoSmithKline
Johnson & Johnson
Neurochem Novo Nordisk
Sanofi-Aventis
Shire
Taro
.plus more
More Canada Prescription Drugs Reports
Canada Pharmaceutical Industry by
Aruvian's R'search
The Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada also has ...
Canada Pharmaceuticals and Healthcare Report Q2 2012 by
Business Monitor International
BMI View: With Canada’s economy set to weather the external storm, the outlook for the country’spharmaceutical market looks relatively stable. Over the longer-term an ageing ...
The Pharmaceutical Market: Canada (pdf/xls) by
Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Pharmaceuticals in Canada by
MarketLine
Introduction Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to 2015). The profile ...
Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis by
Aruvian's R'search
Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose ...
See all reports like this >>
More Canada Reports
D&B Country RiskLine Report: Canada by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Canada by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Canada: Country Profile by
MarketLine
INTRODUCTION This report provides a detailed analysis on Canada, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 Canada Industry & Market Outlook report by
Barnes Reports
The 2007 Canada Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Canada and 500+ minor industries ...
The 2005 Canada Economic and Product Market Databook by
Icon Group International, Inc.
Market Potential Estimation Methodology
Overview
This study covers the outlook products in Canada. For the year reported, estimates are given for the latent demand, or ...
See all reports like this >>
Related Markets
Prescription Drugs Reports
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
- Chinese Markets for Hepatitis Drugs
- Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion

